Navigation Links
Varian Medical Systems Exhibits a New Version of RapidArc(TM) Radiotherapy Technology and Other Products for Fast, Precise Cancer Treatment
Date:9/22/2008

Full spectrum of technologies showcased at the American Society for Therapeutic Radiology and Oncology (ASTRO) meeting in Boston, September

21-24, 2008

BOSTON, Sept. 22 /PRNewswire-FirstCall/ -- ASTRO Booth # 547 -- Varian Medical Systems (NYSE: VAR), world leader in advanced radiotherapy solutions for treating cancer and other disorders, is showcasing a full spectrum of technologies and products for planning and delivering fast, precise cancer treatments at the 50th annual meeting of the American Society for Therapeutic Radiology and Oncology in Boston this week. In addition, the Varian booth at ASTRO includes a glimpse into the company's vision of future technologies for managing cancer care from diagnosis to survivorship. On Display in the ASTRO Booth

On display in Varian's ASTRO booth are the company's world-class technologies for external beam radiotherapy, stereotactic radiosurgery, and brachytherapy, including:

-- A new version of RapidArc(TM) radiotherapy technology, which makes it possible to quickly deliver a volumetric intensity-modulated arc treatment with a single rotation of the treatment machine around the patient. New features include multiple and non-coplanar arc treatments for the accurate targeting of large, irregularly shaped, or awkwardly-positioned tumors. (See related press release entitled Varian to Showcase RapidArc(TM) Radiotherapy Technology Enhancements at ASTRO 2008).

-- The Novalis Tx(TM) image-guided radiosurgery platform, which combines imaging, treatment planning, treatment delivery, and motion management tools from Varian and BrainLAB for the non-invasive treatment of cancer and disorders of the central nervous system. (See related press relea
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Varian to Showcase RapidArc(TM) Radiotherapy Technology Enhancements at ASTRO 2008
2. Transgenomic Announces Partnership With Key Genomics for Ovarian Cancer Assay to Guide Therapeutic Options
3. Varian, Inc. Board of Directors Makes Officer Changes
4. National Ovarian Cancer Coalition and PureOlogy to Host First Annual NOCC and PureOlogys Walk to Break the Silence on Ovarian Cancer
5. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
6. Varian, Inc. to Present at Thomas Weisel Partners 2008 Healthcare Conference
7. New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses
8. Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008
9. New Turbomolecular Pumping System From Varian, Inc. Delivers Portable, Dry, Ultra-high Vacuum.
10. Varian, Inc. Reports Third Quarter 2008 Results
11. Oncolytics Biotech Inc. Announces Start of Enrolment in Phase 1/2 Ovarian Cancer Clinical Trial with REOLYSIN(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... SAN DIEGO , May 16, 2013  The ... the Association of Bioscience Financial Officers (ABFO) 2013 National Conference, ... will be held May 28-31 at the Hilton San ... finishing touches on this year,s conference and want to ... opportunity to attend," said Brandi Roberts ...
(Date:5/16/2013)... Toronto, Canada (PRWEB) May 16, 2013 ... years and costs over one billion dollars. Despite this ... market. With stakes this high, is your clinical trial ... and deliver the best outcomes? , Dr. Frederic Sax, ... Quintiles, will discuss the use of data, information and ...
(Date:5/16/2013)... May 16, 2013 BioInformatics LLC New ... & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) ... of suppliers in the primary cells market continues to ... types are used most often, how satisfied scientists are ... size and anticipated growth rate. ,  , Additionally, ...
(Date:5/16/2013)... A number of residents in an apartment complex in ... abcactionnews.com, it was no thanks to the infestation of ... to the management and everyone else suffering from the pests ... public to try samples of it to prove it themselves ... 2013 determined that the complex invaded by bed ...
Breaking Biology Technology:Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) 2BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) 3Bed Bugs Plague Tarpon Springs Apartment Complex, Non-Pesticide Bed Bug Spray Recommended to Management by My Cleaning Products to Help 2Bed Bugs Plague Tarpon Springs Apartment Complex, Non-Pesticide Bed Bug Spray Recommended to Management by My Cleaning Products to Help 3
... for Pharmaceutical ... ... Codexis, Inc., a private,biotechnology company and leading developer of clean ... California Institute of Technology for preparing and identifying,drug metabolites (substances ...
... Colo., Aug. 29 AspenBio Pharma,Inc. (Nasdaq: APPY ... novel drugs and diagnostics for animals and humans,reported today ... annual Roth,Capital Partners New York Investor Conference to be ... investors are expected to attend the,conference, which will be ...
... of cardiovascular genetics ... ... GeneNews Limited (TSX: GEN),a company focused on developing patient-friendly blood-based ... or medical,condition, today announced that its co-founder and Chief Scientist ...
Cached Biology Technology:Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology 2AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference 2AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference 3GeneNews' Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book 2
(Date:5/17/2013)... AGA Research Foundation announced a new grant that intends ... microbiota, one of today,s most exciting areas of science, ... Research Awards Panel selected Andrew T. Chan, MD, MPH ... Medical School, Boston, as the 2013 AGA-Elsevier Gut Microbiome ... of funding, commencing in July 2013, to test the ...
(Date:5/17/2013)... investigating the interaction of a group of proteins in ... have identified a new target that could increase cell ... University,s School of Biochemistry and published in the ... could eventually lead to new therapies for stroke and ... work by the team which identified a protein, known ...
(Date:5/17/2013)... Societies for Experimental Biology (FASEB) released a new ... trends highlighting the devastating impact of sequestration on the ... follows a May 15th Senate Appropriations Committee hearing featuring ... the $1.6 billion cut the agency sustained in FY ... on the scientific community." , According to data ...
Breaking Biology News(10 mins):New gut microbiome research to explore red meat -- colorectal cancer pathway 2SUMO wrestling cells reveal new protective mechanism target for stroke 2
... - Wheat plants found to be resistant to Hessian ... up rigid defenses. Christie Williams, a research scientist ... and a Purdue University associate professor of entomology, found ... increased production of surface waxes and cutin, a molecule ...
... GALVESTON, Texas Why do people become physically weaker ... stop, or even reverse this process, breaking the link between ... online this Wednesday in the Journal of Clinical Endocrinology ... researchers present evidence that answers to both those questions can ...
... MN Bringing the power of synchrotron light to ... aim of a Memorandum of Agreement (MOA) signed today ... national synchrotron facility, the Canadian Light Source (CLS). ... scientific and product outcomes while improving operating efficiency for ...
Cached Biology News:Resistant wheat rebuilds cell walls when attacked by Hessian flies 2Muscle loss in elderly linked to blood vessels' failure to dilate 2BioBusiness Alliance, Canadian Light Source Synchrotron sign agreement 2
WNV Core Antibody...
Rad51, N-terminal...
Rabbit polyclonal to WWOX8 ( Abpromise for all tested applications). entrezGeneID: 51741 SwissProtID: Q9NZC7-8...
Goat polyclonal to T7 tag (Agarose) Immunogen: Goats were immunized with MASMTGGQQMG (T7) conjugated to KLH.After multiple immunizations in Freund's adjuvant, serum was collected....
Biology Products: